JP2024119984A5 - - Google Patents

Download PDF

Info

Publication number
JP2024119984A5
JP2024119984A5 JP2024096802A JP2024096802A JP2024119984A5 JP 2024119984 A5 JP2024119984 A5 JP 2024119984A5 JP 2024096802 A JP2024096802 A JP 2024096802A JP 2024096802 A JP2024096802 A JP 2024096802A JP 2024119984 A5 JP2024119984 A5 JP 2024119984A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
pharmaceutical according
represented
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024096802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024119984A (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/051594 external-priority patent/WO2020138487A1/ja
Application filed filed Critical
Publication of JP2024119984A publication Critical patent/JP2024119984A/ja
Publication of JP2024119984A5 publication Critical patent/JP2024119984A5/ja
Pending legal-status Critical Current

Links

JP2024096802A 2018-12-28 2024-06-14 TfRに結合するバイスペシフィック抗体 Pending JP2024119984A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018248334 2018-12-28
JP2018248334 2018-12-28
PCT/JP2019/051594 WO2020138487A1 (ja) 2018-12-28 2019-12-27 TfRに結合するバイスペシフィック抗体
JP2020562545A JP7506607B2 (ja) 2018-12-28 2019-12-27 TfRに結合するバイスペシフィック抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020562545A Division JP7506607B2 (ja) 2018-12-28 2019-12-27 TfRに結合するバイスペシフィック抗体

Publications (2)

Publication Number Publication Date
JP2024119984A JP2024119984A (ja) 2024-09-03
JP2024119984A5 true JP2024119984A5 (cg-RX-API-DMAC7.html) 2024-09-25

Family

ID=71125764

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020562545A Active JP7506607B2 (ja) 2018-12-28 2019-12-27 TfRに結合するバイスペシフィック抗体
JP2024096802A Pending JP2024119984A (ja) 2018-12-28 2024-06-14 TfRに結合するバイスペシフィック抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020562545A Active JP7506607B2 (ja) 2018-12-28 2019-12-27 TfRに結合するバイスペシフィック抗体

Country Status (13)

Country Link
US (2) US12258413B2 (cg-RX-API-DMAC7.html)
EP (1) EP3903816A4 (cg-RX-API-DMAC7.html)
JP (2) JP7506607B2 (cg-RX-API-DMAC7.html)
KR (1) KR102991359B1 (cg-RX-API-DMAC7.html)
CN (1) CN113226371B (cg-RX-API-DMAC7.html)
AU (1) AU2019413278B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021012569A2 (cg-RX-API-DMAC7.html)
CA (1) CA3125316A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021007797A (cg-RX-API-DMAC7.html)
MY (1) MY210422A (cg-RX-API-DMAC7.html)
SG (1) SG11202106990PA (cg-RX-API-DMAC7.html)
TW (2) TWI873112B (cg-RX-API-DMAC7.html)
WO (1) WO2020138487A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113563473A (zh) * 2020-04-29 2021-10-29 三生国健药业(上海)股份有限公司 四价双特异性抗体、其制备方法和用途
JP7767613B2 (ja) 2021-11-15 2025-11-11 システィミューン,インコーポレイテッド 二重特異性抗体-カンプトテシン薬物複合体及びその製薬的使用
KR20250160363A (ko) * 2023-03-24 2025-11-12 바이오악틱 에이비 인간 트랜스페린 수용체 htfr1의 프로테아제-유사 도메인에 결합하는 항체
KR20260044219A (ko) 2023-07-21 2026-04-01 매로우 테라퓨틱스, 인크. 조혈 세포 표적화 접합체 및 관련 방법
IL327952A (en) * 2023-10-26 2026-06-01 Biogen Ma Inc Anti-transferrin receptor antibodies and uses thereof

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US570561A (en) 1896-11-03 S peters co
US2808035A (en) 1953-04-23 1957-10-01 Riley Stoker Corp Burning wet materials
JPS5623587A (en) 1979-08-03 1981-03-05 Mitsuwa Seiki Co Ltd Vane type compressor
JPS58110600A (ja) 1981-12-25 1983-07-01 Kyowa Hakko Kogyo Co Ltd ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
WO1985003934A1 (fr) 1984-03-06 1985-09-12 Takeda Chemical Industries, Ltd. Proteine modifiee chimiquement et son procede de preparation
JPS60221091A (ja) 1983-12-21 1985-11-05 Kyowa Hakko Kogyo Co Ltd 新規プロモ−タ−
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
JP2564268B2 (ja) 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
ZA872705B (en) 1986-04-22 1987-10-05 Immunex Corporation Human g-csf protein expression
JP2958019B2 (ja) 1988-05-06 1999-10-06 住友製薬株式会社 ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法
JP2928287B2 (ja) 1988-09-29 1999-08-03 協和醗酵工業株式会社 新規ポリペプチド
JPH02257891A (ja) 1989-03-31 1990-10-18 Kyowa Hakko Kogyo Co Ltd 組換え動物細胞による蛋白質の製造
JPH0322979A (ja) 1989-06-19 1991-01-31 Kyowa Hakko Kogyo Co Ltd 新規プラスミノーゲン活性化因子
JP3131322B2 (ja) 1991-12-17 2001-01-31 協和醗酵工業株式会社 新規α2→3シアリルトランスフェラーゼ
US6042828A (en) 1992-09-07 2000-03-28 Kyowa Hakko Kogyo Co., Ltd. Humanized antibodies to ganglioside GM2
WO1994023021A1 (fr) 1993-03-29 1994-10-13 Kyowa Hakko Kogyo Co., Ltd. α-1,3-FUCOSYLTRANSFERASE
US5705614A (en) 1993-04-09 1998-01-06 Chiron Corporation Methods of producing antigen forks
CA2222231A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
ES2233974T3 (es) 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
US6001358A (en) 1995-11-07 1999-12-14 Idec Pharmaceuticals Corporation Humanized antibodies to human gp39, compositions containing thereof
EP0979281B1 (en) 1997-05-02 2005-07-20 Genentech, Inc. A method for making multispecific antibodies having heteromultimeric and common components
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6528624B1 (en) 1998-04-02 2003-03-04 Genentech, Inc. Polypeptide variants
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
HUP0104865A3 (en) 1999-01-15 2004-07-28 Genentech Inc Polypeptide variants with altered effector function
EP2275540B1 (en) 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
PT2857516T (pt) 2000-04-11 2017-08-28 Genentech Inc Anticorpos multivalentes e utilizações dos mesmos
PT2990420T (pt) * 2000-05-26 2017-03-16 Immunex Corp Uso de anticorpos de recetor de interleucina-4 e composições dos mesmos
PE20020132A1 (es) 2000-06-29 2002-03-04 Abbott Lab Anticuerpos de especificidad doble y metodos para la elaboracion y el uso de los mismos
CN103333860B (zh) 2000-10-06 2015-07-08 协和发酵麒麟株式会社 产生抗体组合物的细胞
EP1369431A4 (en) 2001-10-15 2005-01-12 Kirin Brewery ANTI-HLA-DR ANTIBODIES
US7317091B2 (en) 2002-03-01 2008-01-08 Xencor, Inc. Optimized Fc variants
JPWO2005035586A1 (ja) 2003-10-08 2007-11-22 協和醗酵工業株式会社 融合蛋白質組成物
JP4958555B2 (ja) 2004-09-22 2012-06-20 協和発酵キリン株式会社 安定化されたヒトIgG4抗体
US7923538B2 (en) 2005-07-22 2011-04-12 Kyowa Hakko Kirin Co., Ltd Recombinant antibody composition
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
EP2281845B1 (en) 2008-04-25 2020-09-02 Kyowa Kirin Co., Ltd. Stable polyvalent antibody
US9221902B2 (en) * 2008-11-07 2015-12-29 Fabrus, Inc. Combinatorial antibody libraries and uses thereof
CN102459344A (zh) * 2009-05-15 2012-05-16 中外制药株式会社 抗axl抗体
CN102803484A (zh) 2009-06-11 2012-11-28 大学共同利用机关法人情报·系统研究机构 生产蛋白质的方法
WO2011116387A1 (en) 2010-03-19 2011-09-22 Tetragenetics, Inc. Production of aglycosylated monoclonal antibodies in ciliates
CN103443125B (zh) * 2010-11-30 2019-05-03 霍夫曼-拉罗奇有限公司 低亲和力血脑屏障受体抗体及其用途
US9206257B2 (en) 2011-04-19 2015-12-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human monoclonal antibodies specific for glypican-3 and use thereof
US9598496B2 (en) 2011-05-09 2017-03-21 Perseus Proteomics Inc. Antibody capable of specifically recognizing transferrin receptor
US8691231B2 (en) 2011-06-03 2014-04-08 Merrimack Pharmaceuticals, Inc. Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
US9527927B2 (en) 2011-12-20 2016-12-27 Medimmune, Llc Modified polypeptides for bispecific antibody scaffolds
SG10201704846VA (en) 2012-03-14 2017-07-28 Regeneron Pharma Multispecific antigen-binding molecules and uses thereof
WO2013177062A2 (en) 2012-05-21 2013-11-28 Genentech, Inc. Methods for improving safety of blood-brain barrier transport
SG11201509566RA (en) 2013-05-20 2015-12-30 Genentech Inc Anti-transferrin receptor antibodies and methods of use
US9388243B2 (en) 2013-05-29 2016-07-12 Samsung Electronics Co., Ltd. Method of target membrane protein depletion
TWI702316B (zh) * 2013-12-04 2020-08-21 日商中外製藥股份有限公司 因應化合物濃度使抗原結合能力變化的抗原結合分子及其資料庫
AU2015242752A1 (en) * 2014-04-04 2016-10-20 Kyowa Hakko Kirin Co., Ltd. Anti-death receptor 3 (DR3) antagonistic antibodies with reduced agonistic activity
JP6779876B2 (ja) * 2014-11-19 2020-11-04 ジェネンテック, インコーポレイテッド 抗トランスフェリン受容体抗体及びその使用方法
EP3221361B1 (en) * 2014-11-19 2021-04-21 Genentech, Inc. Anti-transferrin receptor / anti-bace1 multispecific antibodies and methods of use
US20180016346A1 (en) * 2015-01-08 2018-01-18 Kyowa Hakko Kirin Co., Ltd Bispecific antibody binding to trailr2 and psma
AU2016282334B2 (en) * 2015-06-24 2022-07-21 F. Hoffmann-La Roche Ag Anti-transferrin receptor antibodies with tailored affinity
TWI726897B (zh) * 2015-07-15 2021-05-11 日商協和麒麟股份有限公司 與人類crth2特異性結合之抗體
US20190161535A1 (en) * 2016-05-09 2019-05-30 Annexon, Inc. Compositions and methods for treating spinal muscular atrophy
KR102156626B1 (ko) 2018-07-16 2020-09-17 주식회사 셀바스에이아이 운동 처방 정보를 제공하는 서버 및 컴퓨터 프로그램

Similar Documents

Publication Publication Date Title
US10913796B2 (en) Antibodies targeting Fc receptor-like 5 and methods of use
JP2022512234A5 (cg-RX-API-DMAC7.html)
US11566071B2 (en) Nucleic acid molecules encoding anti-GPRC5D antibodies
JP6669722B2 (ja) Cd3結合ドメイン
JP2023548443A5 (cg-RX-API-DMAC7.html)
CN113583116B (zh) 针对SARS-CoV-1或SARS-CoV-2的抗体及其用途
JP2020524661A5 (cg-RX-API-DMAC7.html)
JP2013515508A5 (cg-RX-API-DMAC7.html)
JP2011526249A5 (cg-RX-API-DMAC7.html)
JP2026004299A5 (cg-RX-API-DMAC7.html)
JP2022504826A5 (cg-RX-API-DMAC7.html)
JP2021518132A5 (cg-RX-API-DMAC7.html)
JP2020502233A5 (cg-RX-API-DMAC7.html)
JP2017509323A5 (cg-RX-API-DMAC7.html)
JPWO2020138487A5 (cg-RX-API-DMAC7.html)
JP2023506834A5 (cg-RX-API-DMAC7.html)
Kiprlyanov et al. Recent advances in the generation of bispecific antibodies for tumor immunotherapy
JPWO2024085166A5 (cg-RX-API-DMAC7.html)
JP2025511000A5 (cg-RX-API-DMAC7.html)
JP2024537398A5 (cg-RX-API-DMAC7.html)
RU2025100420A (ru) Слитые белки фоллистатин-fc
RU2022103028A (ru) Антитела против рецептора программируемой смерти pd-1 человека
WO2025190376A1 (zh) 抗cd161抗体及其用途
HK1240236A1 (en) Cd3 binding domain
HK40002168B (en) Antibodies targeting fc receptor-like 5 and methods of use